rfhg_120098.1

Basic information about the TSS

---

TSS ID: rfhg_120098.1 TSS ID(Version3): hg_102771.1 hg_102769.1 hg_102770.1 Species: human Chr: chr9		Start: 129835184 End: 129835314 Strand: -
Source datasets	FANTOM5|PRJNA548673|PRJNA615891|PRJNA401781|PRJNA597322 |PRJNA4843412|DRA013844|PRJDB5282
Protocol	CAGE|TIF-seq2|RAMPAGE|oligo_capping|ReCappable-seq |SLIC_CAGE|STRIPE-seq|NETCAGE|C1CAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D4244456,EH38E2730895)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Transcript_name: ENST00000372447.7 ENST00000461349.5 ENST00000492991.5 AF218421 AK057004 BC017570 AF151054 BC007664 CU675747 CU676010 Distance: 0 GeneID: 51759 HGNC/MGI_ID: HGNC:24932 UniProt_ID: Q9NZ63 Q9P0Q6

Gene_name: C9orf78 Gene_symbol: C9orf78 Gene_synonyms: CSU2 HCA59 HSPC220 Gene_source: HGNC:24932

TATA-Box annotation

---

Distance to TSS:	26
Nearest PromoterID:	NM_016520
Entrez ID:	51759
Nearest Unigene:	Hs.278429
Nearest Refseq:	NM_016520
Nearest Ensembl:	ENSG00000136819
Gene Name:	C9orf78
Gene Alias:	CSU2|HCA59|HSPC220|bA409K20.3
Gene Description:	chromosome 9 open reading frame 78
Gene Type:	protein-coding
CpG%:	0.153846
GC%:	0.732824
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@C9orf78 p2@C9orf78
Sample		p1@C9orf78	p2@C9orf78
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	29.80	6.23
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	25.69	7.28
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	32.02	6.94
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.25	4.99
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	24.07	3.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	27.71	6.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.74	10.02
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	25.92	7.02
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	24.58	5.34
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	13.74	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	13.42	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.28	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.78	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.83	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.83	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.79	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.08	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.24	1.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.10	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.85	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	14.74	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.74	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.42	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.56	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.93	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	14.38	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.63	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.58	3.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.47	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.48	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.40	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.76	2.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	17.58	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.18	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.49	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.29	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	18.64	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.88	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.69	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.13	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.81	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.07	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.82	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.43	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.01	2.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	14.84	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.35	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.35	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.23	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	391.78	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	8.62	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	69.63	14.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	26.18	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.16	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.95	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.73	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	26.27	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.65	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	10.72	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.45	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	420.26	129.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	292.21	94.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.29	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.92	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.44	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.57	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.75	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.37	1.53
Adipocyte - breast, donor1	11376-118A8	49.73	7.92
Adipocyte - breast, donor2	11327-117E4	33.21	7.86
Adipocyte - omental, donor1	11473-119C6	51.53	8.14
Adipocyte - omental, donor2	11474-119C7	30.65	10.46
Adipocyte - omental, donor3	11475-119C8	21.43	4.35
Adipocyte - perirenal, donor1	11476-119C9	28.07	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	6.60
Adipocyte - subcutaneous, donor2	11336-117F4	38.39	5.87
Adipocyte - subcutaneous, donor3	11408-118E4	23.98	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	32.07	5.87
Adipocyte differentiation, day04, donor2	13022-139D7	24.19	4.63
Adipocyte differentiation, day04, donor3	13025-139E1	32.90	7.53
Adipocyte differentiation, day04, donor4	13028-139E4	42.32	4.70
Adipocyte differentiation, day08, donor1	13020-139D5	44.08	5.63
Adipocyte differentiation, day08, donor2	13023-139D8	41.31	5.81
Adipocyte differentiation, day08, donor3	13026-139E2	30.39	9.06
Adipocyte differentiation, day08, donor4	13029-139E5	22.81	3.90
Adipocyte differentiation, day12, donor1	13021-139D6	27.86	5.41
Adipocyte differentiation, day12, donor2	13024-139D9	27.63	3.77
Adipocyte differentiation, day12, donor3	13027-139E3	28.14	6.54
Adipocyte differentiation, day12, donor4	13030-139E6	25.27	3.65
Alveolar Epithelial Cells, donor1	11510-119G7	19.89	2.65
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.99	2.52
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.85	1.23
Anulus Pulposus Cell, donor1	11248-116E6	39.13	3.55
Anulus Pulposus Cell, donor2	11463-119B5	21.55	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	21.57	9.44
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	22.14	9.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.11	5.98
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	12.65
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	4.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.34	7.47
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.73	8.74
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	33.85	6.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	9.42
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	8.71
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.89	5.77
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	8.19
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.77	3.47
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.75	6.43
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.53	6.05
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	33.14	6.15
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	5.85
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	28.03	6.47
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	26.59	5.83
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	12.58
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.39	6.31
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	32.25	5.69
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	31.50	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.81	7.41
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	25.87	6.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	26.07	3.87
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	16.89	5.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.62	8.04
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.30	7.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.71	6.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	9.50
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	23.39	6.10
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.78	6.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.88	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	23.73	6.47
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.98	4.66
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.33	3.77
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	25.51	7.56
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.33	4.24
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	16.90
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.30	4.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	10.21
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.18	7.36
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	28.05	15.30
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.95	4.32
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.80	5.37
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.95	4.59
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	25.81	10.52
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.83	4.66
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	9.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.17	8.86
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.19	5.83
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.17	4.72
Astrocyte - cerebellum, donor1	11500-119F6	21.49	3.19
Astrocyte - cerebellum, donor2	11580-120F5	9.07	1.20
Astrocyte - cerebellum, donor3	11661-122F5	6.29	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	46.71	6.27
Astrocyte - cerebral cortex, donor2	11316-117D2	38.18	4.21
Astrocyte - cerebral cortex, donor3	11392-118C6	32.82	5.37
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	60.90	10.09
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	66.15	14.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	68.62	10.58
Basophils, donor1	12241-129G9	139.92	18.31
Basophils, donor2	12242-129H1	268.43	45.10
Basophils, donor3	12243-129H2	93.49	14.70
Bronchial Epithelial Cell, donor1	11511-119G8	12.29	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	18.83	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	10.40	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	12.44	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	34.19	3.78
Burkitt's lymphoma cell line:DAUDI	10422-106C8	59.05	20.71
Burkitt's lymphoma cell line:RAJI	10476-106I8	92.46	14.67
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	86.98	11.83
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	10.34
CD14+ Monocytes, donor1	11224-116B9	73.26	11.83
CD14+ Monocytes, donor2	11305-117B9	102.08	14.66
CD14+ Monocytes, donor3	11381-118B4	82.55	12.95
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	64.25	7.93
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	80.36	9.48
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	77.25	8.55
CD14+ monocytes - mock treated, donor1	11863-125A9	54.21	14.74
CD14+ monocytes - mock treated, donor2	11873-125C1	50.99	13.58
CD14+ monocytes - mock treated, donor3	11883-125D2	56.38	16.11
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	38.00	7.37
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	24.84	5.52
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	29.75	8.43
CD14+ monocytes - treated with BCG, donor1	11860-125A6	26.63	4.50
CD14+ monocytes - treated with BCG, donor2	11870-125B7	28.49	6.94
CD14+ monocytes - treated with BCG, donor3	11880-125C8	38.30	8.27
CD14+ monocytes - treated with Candida, donor1	11868-125B5	32.54	5.62
CD14+ monocytes - treated with Candida, donor2	11878-125C6	44.35	10.03
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	7.77
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.66	9.52
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	34.72	11.77
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	54.34	11.45
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	34.09	8.01
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	41.62	9.50
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	26.19	7.42
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	48.42	10.49
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	42.39	11.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	47.13	11.36
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.02	4.04
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.26	3.52
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.48	3.95
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	25.11	5.58
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	28.25	6.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	42.46	8.62
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	20.47	6.14
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	27.35	5.10
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.23	7.42
CD14+CD16+ Monocytes, donor1	11789-124B7	131.43	24.41
CD14+CD16+ Monocytes, donor2	11801-124D1	114.57	21.94
CD14+CD16+ Monocytes, donor3	11912-125G4	102.46	18.63
CD14+CD16- Monocytes, donor1	11788-124B6	95.77	19.31
CD14+CD16- Monocytes, donor2	11799-124C8	78.42	11.88
CD14+CD16- Monocytes, donor3	11910-125G2	149.84	27.87
CD14-CD16+ Monocytes, donor1	11790-124B8	115.34	17.10
CD14-CD16+ Monocytes, donor2	11800-124C9	114.39	19.76
CD14-CD16+ Monocytes, donor3	11911-125G3	139.17	19.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	95.52	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	89.49	12.88
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	107.70	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	91.15	9.06
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	146.88	16.62
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	101.78	8.42
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	7.84
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	113.37	14.50
CD19+ B Cells, donor1	11544-120B5	107.67	23.01
CD19+ B Cells, donor2	11624-122B4	111.72	16.68
CD19+ B Cells, donor3	11705-123B4	113.08	14.14
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	909.94	129.30
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	548.90	75.50
CD34+ Progenitors, donor1	11545-120B6	72.29	10.04
CD34+ Progenitors, donor2	11625-122B5	111.24	20.79
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.78	16.53
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	81.40	16.91
CD4+ T Cells, donor1	11225-116C1	362.77	43.56
CD4+ T Cells, donor2	11306-117C1	278.63	31.23
CD4+ T Cells, donor3	11382-118B5	221.12	32.33
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	129.92	28.84
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	133.64	24.93
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	135.97	19.55
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	209.07	16.12
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	182.60	20.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	204.37	16.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	116.62	31.50
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	89.65	16.44
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	80.93	16.60
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	150.18	28.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	154.08	25.51
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	222.63	35.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	182.99	43.43
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	94.74	19.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	92.89	26.40
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	246.92	17.95
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	224.03	27.87
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	208.01	23.31
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	147.23	34.86
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	101.38	21.66
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	104.87	19.12
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	164.83	27.30
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	159.87	27.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	275.87	28.76
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	223.19	21.28
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	192.95	20.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	192.62	12.56
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	243.70	27.14
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	277.54	39.75
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	247.94	26.18
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	203.05	22.20
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	221.60	20.77
CD8+ T Cells, donor1	11226-116C2	318.56	55.33
CD8+ T Cells, donor2	11307-117C2	232.02	51.06
CD8+ T Cells, donor3	11383-118B6	249.96	43.18
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	9.18
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	27.56	6.95
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	28.18	8.21
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.32	12.01
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.60	5.04
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.42	8.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.51	8.69
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	7.11
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.16	8.21
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	25.06	7.85
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.37	11.33
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	23.18	9.06
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.57	7.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	16.40	7.74
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	5.22
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.77	8.28
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.15	7.77
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	27.11	6.60
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	27.57	8.56
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	24.61	9.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	22.12	6.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	23.71	7.65
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.10	3.94
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	9.83
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	25.69	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	20.28	7.69
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	25.04	4.01
Cardiac Myocyte, donor1	11525-119I4	71.28	5.48
Cardiac Myocyte, donor2	11605-120I3	13.34	3.46
Cardiac Myocyte, donor3	11686-122I3	23.78	3.37
Chondrocyte - de diff, donor1	11261-116G1	35.71	7.63
Chondrocyte - de diff, donor2	11338-117F6	24.17	5.33
Chondrocyte - de diff, donor3	11410-118E6	28.56	4.89
Chondrocyte - re diff, donor2	11339-117F7	90.42	11.64
Chondrocyte - re diff, donor3	11411-118E7	27.90	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	39.25	3.44
Ciliary Epithelial Cells, donor2	11323-117D9	26.51	4.28
Ciliary Epithelial Cells, donor3	11399-118D4	30.62	5.66
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	85.56	8.44
Corneal Epithelial Cells, donor1	11526-119I5	7.47	0.88
Corneal Epithelial Cells, donor2	11606-120I4	13.65	1.14
Corneal Epithelial Cells, donor3	11687-122I4	8.18	1.28
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.80	12.22
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	64.03	8.83
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	35.53	8.42
Dendritic Cells - plasmacytoid, donor1	11228-116C4	97.71	12.64
Dendritic Cells - plasmacytoid, donor2	11309-117C4	113.60	15.02
Dendritic Cells - plasmacytoid, donor3	11385-118B8	138.41	17.91
Endothelial Cells - Aortic, donor0	11207-116A1	24.18	4.67
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	2.93
Endothelial Cells - Aortic, donor2	11340-117F8	35.92	5.66
Endothelial Cells - Aortic, donor3	11412-118E8	34.99	7.08
Endothelial Cells - Artery, donor1	11264-116G4	22.98	4.07
Endothelial Cells - Artery, donor2	11341-117F9	27.06	5.18
Endothelial Cells - Artery, donor3	11413-118E9	18.93	3.51
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.60	3.10
Endothelial Cells - Lymphatic, donor2	11317-117D3	35.90	5.17
Endothelial Cells - Lymphatic, donor3	11393-118C7	41.44	5.64
Endothelial Cells - Microvascular, donor1	11265-116G5	23.47	4.75
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	14.32	1.70
Endothelial Cells - Thoracic, donor1	11266-116G6	37.21	8.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	56.16	8.95
Endothelial Cells - Umbilical vein, donor2	11324-117E1	45.41	5.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	48.85	6.96
Endothelial Cells - Vein, donor1	11267-116G7	6.83	1.14
Endothelial Cells - Vein, donor2	11344-117G3	13.27	1.40
Endothelial Cells - Vein, donor3	11416-118F3	18.84	3.77
Eosinophils, donor1	12244-129H3	320.19	45.74
Eosinophils, donor2	12245-129H4	267.34	33.01
Eosinophils, donor3	12246-129H5	160.51	14.27
Esophageal Epithelial Cells, donor1	11507-119G4	7.09	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	35.30	6.16
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.33	3.61
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.94	3.68
Fibroblast - Aortic Adventitial, donor1	11245-116E3	43.54	8.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	26.07	5.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.11	4.01
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	17.13	3.69
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.20	6.64
Fibroblast - Cardiac, donor1	11268-116G8	27.22	3.63
Fibroblast - Cardiac, donor2	11345-117G4	9.10	3.79
Fibroblast - Cardiac, donor3	11417-118F4	19.56	4.89
Fibroblast - Cardiac, donor4	11452-119A3	45.16	5.15
Fibroblast - Cardiac, donor5	11456-119A7	27.28	4.82
Fibroblast - Cardiac, donor6	11460-119B2	29.41	3.34
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.93	2.68
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.98	3.45
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	14.99	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	40.87	5.09
Fibroblast - Dermal, donor1	11269-116G9	35.22	6.57
Fibroblast - Dermal, donor2	11346-117G5	26.89	8.49
Fibroblast - Dermal, donor3	11418-118F5	27.44	3.14
Fibroblast - Dermal, donor4	11450-119A1	29.62	4.63
Fibroblast - Dermal, donor5	11454-119A5	30.35	5.76
Fibroblast - Dermal, donor6	11458-119A9	43.69	7.63
Fibroblast - Gingival, donor1	11237-116D4	40.81	6.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	40.61	8.65
Fibroblast - Gingival, donor2	11318-117D4	35.71	5.27
Fibroblast - Gingival, donor3	11394-118C8	33.26	4.16
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	29.09	5.19
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.78	3.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.34	7.79
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.27	6.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.53	3.88
Fibroblast - Gingival, donor7 (control)	11924-125H7	40.80	7.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	51.54	9.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.90	10.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	38.45	5.72
Fibroblast - Lung, donor1	11270-116H1	13.59	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	5.97
Fibroblast - Lung, donor3	11419-118F6	31.02	3.80
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	5.59
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	0.28
Fibroblast - Mammary, donor1	11540-120B1	39.38	7.31
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.20	4.66
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.36	7.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	57.22	10.10
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	42.74	6.49
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	30.24	6.75
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	30.85	3.48
Fibroblast - Pulmonary Artery, donor1	11250-116E8	31.17	5.97
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.32	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.71	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.12	3.95
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	22.23	5.75
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	39.61	4.62
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	45.72	6.50
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	16.55	8.42
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	48.47	10.90
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.21	3.04
Fibroblast - skin normal, donor1	11553-120C5	40.69	6.23
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.47	5.01
Fibroblast - skin normal, donor2	11561-120D4	49.53	10.15
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.97	5.74
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	49.54	5.96
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	49.23	7.69
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.99	6.90
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	52.62	9.48
Fibroblast - skin walker warburg, donor1	11554-120C6	35.42	17.21
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	43.91	6.90
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	775.59	354.56
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.91	15.69
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.34	11.27
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	42.42	9.11
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	44.71	8.69
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	23.73	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	24.25	6.38
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	80.44	13.12
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.02	4.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	34.48	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	44.58	7.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	33.57	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.09	5.54
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	59.26	11.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.75	8.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.31	8.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.38	5.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	32.09	5.58
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	34.05	7.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.37	6.30
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.63	7.07
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.89	7.47
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.88	4.15
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	33.98	6.50
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.00	6.52
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	34.85	4.47
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.29	3.63
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.88	7.29
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	58.17	10.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	48.39	6.97
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.21	8.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	34.52	6.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.75	7.57
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.92	7.76
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.28	5.36
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.70	5.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	37.52	5.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	32.40	3.53
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.05	7.38
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.69	5.35
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	43.94	3.21
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.61	5.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.47	3.80
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	44.09	3.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	30.94	6.69
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.54	3.95
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	37.87	4.77
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.96	8.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.59	6.95
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	41.16	8.11
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	30.96	8.16
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.31	5.69
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	39.64	9.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	35.09	4.39
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	9.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	33.77	6.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	26.23	4.84
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	62.78	7.12
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	64.10	14.53
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.37	10.94
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	65.06	20.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.42	8.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	33.91	6.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	40.12	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	12.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	43.32	11.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	25.67	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	36.13	6.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	45.71	8.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	31.32	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	37.26	3.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.14	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	33.40	7.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	39.40	6.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	29.23	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	40.09	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	30.78	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	10.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	48.05	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	31.99	5.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	27.68	5.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	29.99	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.75	4.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	39.68	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.63	6.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.84	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	25.35	7.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	25.94	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.92	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	32.56	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	43.68	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	28.59	4.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	41.69	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	33.06	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	25.07	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.54	2.91
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	20.54	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	18.30	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	32.35	5.39
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.63	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	55.70	17.17
Hep-2 cells mock treated, biol_rep2	11899-125E9	57.39	14.69
Hep-2 cells mock treated, biol_rep3	11900-125F1	57.56	15.47
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	47.99	11.48
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	63.18	11.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	54.68	16.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	58.28	13.33
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	57.98	12.52
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	53.18	13.14
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.35	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	25.53	5.42
Hepatocyte, donor1	11523-119I2	85.95	15.74
Hepatocyte, donor2	11603-120I1	108.81	12.93
Hepatocyte, donor3	11684-122I1	61.97	7.36
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	101.17	11.10
Intestinal epithelial cells (polarized), donor1	11246-116E4	69.04	13.98
Iris Pigment Epithelial Cells, donor1	11530-119I9	27.72	3.43
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	15.23
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	20.50
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	37.36	11.37
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	11.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	38.38	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	46.56	14.41
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	40.31	14.49
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	30.36	12.27
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	30.97	12.22
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	27.71	7.14
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	42.60	13.66
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	44.37	13.69
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.02	9.98
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	33.36	6.46
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	27.95	10.16
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	24.23	12.12
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.85	10.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	54.02	19.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	12.57
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	37.55	8.34
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	9.60
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	8.55
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	14.73
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	4.23
Keratinocyte - epidermal, donor1	11272-116H3	45.45	7.75
Keratinocyte - epidermal, donor2	11349-117G8	8.20	2.93
Keratinocyte - epidermal, donor3	11421-118F8	35.02	7.00
Keratinocyte - oral, donor1	11251-116E9	53.69	7.72
Keratocytes, donor1	11527-119I6	12.72	1.38
Keratocytes, donor2	11607-120I5	8.20	1.17
Keratocytes, donor3	11688-122I5	26.68	4.54
Krukenberg tumor cell line:HSKTC	10687-109F3	160.45	26.37
Lens Epithelial Cells, donor1	11529-119I8	25.89	7.55
Lens Epithelial Cells, donor2	11609-120I7	42.44	4.73
Lens Epithelial Cells, donor3	11690-122I7	45.81	7.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.64	5.45
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	16.74	3.07
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.69	7.40
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	18.82	4.30
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.69	4.73
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	22.86	3.88
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.57	3.69
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	12.89	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	23.79	5.49
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	24.13	7.52
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.49	5.43
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.52	2.78
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	21.95	4.88
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.84	5.25
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	19.92	4.53
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.25	3.39
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	17.15	3.12
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.52	5.86
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.76	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.23	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	14.94	4.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.28	7.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.39	7.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	25.13	6.66
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	26.44	5.18
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.31	7.33
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.35	3.61
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.76	6.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.75	3.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.31	4.77
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.32	11.15
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.17	3.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	18.83	4.58
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	6.66
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.77	4.20
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.91	4.40
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.80	4.18
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	22.22	6.09
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	28.41	5.60
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	26.67	3.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.51	6.30
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.78	4.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.99	4.66
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	23.19	3.92
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.18	4.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	41.33	6.19
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.34	4.10
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	18.50	4.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	30.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	22.27	5.94
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.12	6.77
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	4.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	32.98	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.30	5.43
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	38.68	8.72
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	44.57	6.30
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	37.53	5.15
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	30.81	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.17	8.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.98	7.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	31.07	7.64
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	34.42	6.94
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	47.99	6.24
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	35.59	4.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	27.72	8.97
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	50.19	9.16
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	49.61	7.85
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	29.88	7.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	49.06	6.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	37.96	5.68
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	35.96	5.53
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	33.23	8.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.45	5.16
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	9.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.83	5.37
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	31.14	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	28.72	3.28
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.21	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.85	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.86	5.98
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	37.53	5.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	33.17	3.02
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	26.55	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	33.98	9.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	38.61	5.43
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	19.91	4.27
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.12	5.16
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	30.59	5.90
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	29.63	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	32.97	7.04
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	35.96	4.23
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	38.81	6.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	20.35	5.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	26.06	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.17	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	23.52	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	24.64	6.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	28.39	4.51
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	25.38	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	29.72	5.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.31	7.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	32.17	7.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	38.94	7.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	41.93	5.59
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	31.36	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	33.94	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	36.46	5.57
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	33.64	4.81
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.19	6.76
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	40.10	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	20.75	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.94	5.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	39.76	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	29.02	6.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	39.61	6.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	34.65	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.79	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.28	5.14
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.20	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	20.43	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	34.11	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.85	6.26
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	28.81	5.11
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	7.36
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	22.99	7.48
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.16	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	30.29	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	29.63	9.69
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	21.47	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	28.45	5.47
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	33.85	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.30	7.28
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	28.51	7.96
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	6.24
Macrophage - monocyte derived, donor1	11232-116C8	44.44	6.38
Macrophage - monocyte derived, donor2	11313-117C8	37.07	6.24
Macrophage - monocyte derived, donor3	11389-118C3	32.25	4.06
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	40.36	7.97
Mallassez-derived cells, donor2	11929-125I3	65.44	14.74
Mallassez-derived cells, donor3	11930-125I4	68.66	15.29
Mammary Epithelial Cell, donor1	11273-116H4	51.71	10.26
Mammary Epithelial Cell, donor2	11350-117G9	41.98	10.71
Mammary Epithelial Cell, donor3	11422-118F9	10.23	1.50
Mast cell - stimulated, donor1	11487-119E2	178.98	40.00
Mast cell, donor1	11563-120D6	86.84	18.28
Mast cell, donor2	11565-120D8	100.15	19.02
Mast cell, donor3	11566-120D9	125.17	8.55
Mast cell, donor4	11567-120E1	93.43	8.69
Mast cell, expanded and stimulated, donor5	11940-126A5	81.95	13.20
Mast cell, expanded and stimulated, donor8	11942-126A7	83.47	15.18
Mast cell, expanded, donor5	11939-126A4	74.91	12.16
Mast cell, expanded, donor8	11941-126A6	88.20	17.91
Melanocyte - dark, donor1	11502-119F8	43.38	6.77
Melanocyte - dark, donor2	11582-120F7	18.34	2.08
Melanocyte - dark, donor3	11663-122F7	59.33	8.48
Melanocyte - light, donor1	11274-116H5	21.16	2.59
Melanocyte - light, donor2	11351-117H1	10.92	2.05
Melanocyte - light, donor3	11423-118G1	11.27	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	35.09	6.46
Melanocyte, donor2 (MC+2)	12739-135I3	38.46	5.38
Melanocyte, donor3 (MC+3)	12837-137B2	47.68	7.77
Meningeal Cells, donor1	11493-119E8	34.86	4.47
Meningeal Cells, donor2	11573-120E7	29.93	5.28
Meningeal Cells, donor3	11654-122E7	52.24	8.39
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.06	5.42
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	38.34	7.35
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	7.89
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	31.98	5.93
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.67	5.03
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.82	2.42
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	5.84
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.50	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	34.21	3.74
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.32	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.71	3.68
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.09	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	13.45	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.47	6.73
Mesenchymal stem cells - hepatic, donor0	11218-116B3	26.58	2.81
Mesenchymal stem cells - umbilical, donor0	11214-116A8	31.93	5.08
Mesothelial Cells, donor1	11247-116E5	28.11	4.24
Mesothelial Cells, donor2	12156-128G5	23.02	4.50
Mesothelial Cells, donor3	11402-118D7	23.27	2.53
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	140.43	24.31
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	47.78	9.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	51.24	9.13
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	10.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.33	4.96
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	35.89	7.68
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	39.04	7.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	59.58	9.31
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.26	5.08
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	37.22	8.32
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	21.24	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	34.57	4.94
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	46.06	10.53
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.38	4.24
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	40.52	7.37
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.42	3.28
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	67.07	20.12
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	20.32	4.27
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	36.84	4.99
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	40.91	4.98
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.72	4.37
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	29.24	7.78
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.57	3.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	21.45	5.58
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.57	6.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.74	3.29
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	33.97	10.14
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	46.40	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.73	4.08
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	27.64	4.71
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	39.25	9.81
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.21	3.36
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	42.51	6.86
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.52	4.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	40.77	12.23
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	20.14	6.13
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	46.35	5.52
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	33.94	3.84
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	23.55	5.45
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	50.80	7.65
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	50.83	15.47
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	26.32	5.13
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	31.95	7.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	48.65	11.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	24.41	5.33
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	46.97	12.88
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	42.54	11.07
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.34	4.52
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	46.75	10.02
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	72.19	57.75
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	12.01
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	54.07	13.09
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.65	15.20
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.36	5.96
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	48.47	18.02
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	45.73	12.70
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	30.96	9.87
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	43.10	9.58
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.28	6.64
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	25.80	7.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	50.86	13.49
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	49.68	14.03
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	31.54	11.65
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	40.31	10.32
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	32.58	11.08
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	34.99	10.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	40.94	6.63
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	62.65	9.07
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	34.25	7.15
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	38.11	6.57
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.04	2.97
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	47.50	6.52
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	45.06	6.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	32.76	3.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	46.48	6.67
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	27.26	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	35.18	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	7.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	67.87	13.90
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	26.26	4.04
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	40.48	7.59
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	80.35	16.34
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	43.87	4.45
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	69.65	9.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	51.35	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	117.45	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	80.79	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	48.04	7.97
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	43.38	6.27
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	4.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	18.36	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	58.75	10.46
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	134.05	39.90
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.28	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	292.18	45.94
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.63	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.36	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.53	5.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	723.76	89.08
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.88	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.57	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.29	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.92	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.42	5.47
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.26	4.24
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	65.96	12.47
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	8.62	1.14
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	43.21	6.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.11	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	13.18	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	59.32	6.90
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	409.61	65.74
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	35.87	5.12
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.89	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.74	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	821.53	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.33	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	25.25	6.76
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.71	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	11.14	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.30	2.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.66	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	36.18	7.69
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	7.98	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	19.35	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.08	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.52	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	32.27	5.53
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	383.21	45.99
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	13.41	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.27	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.74	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	62.35	15.87
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	354.05	50.58
Myoblast, donor1	11241-116D8	38.51	8.82
Myoblast, donor2	11322-117D8	21.48	13.04
Myoblast, donor3	11398-118D3	47.76	7.74
NK T cell leukemia cell line:KHYG-1	10777-110G3	89.31	15.32
Natural Killer Cells, donor1	11230-116C6	254.62	51.97
Natural Killer Cells, donor2	11311-117C6	206.26	31.36
Natural Killer Cells, donor3	11387-118C1	171.72	32.21
Neural stem cells, donor1	11275-116H6	118.68	26.49
Neural stem cells, donor2	11352-117H2	115.54	28.88
Neurons, donor1	11494-119E9	75.10	11.38
Neurons, donor2	11574-120E8	73.31	14.75
Neurons, donor3	11655-122E8	40.29	9.04
Neutrophils, donor1	11233-116C9	94.66	12.06
Neutrophils, donor2	11314-117C9	92.76	8.70
Neutrophils, donor3	11390-118C4	99.57	9.77
Nucleus Pulposus Cell, donor1	11252-116F1	41.68	3.92
Nucleus Pulposus Cell, donor2	11409-118E5	18.88	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	20.46	1.60
Olfactory epithelial cells, donor1	11933-125I7	25.47	3.17
Olfactory epithelial cells, donor2	11934-125I8	26.92	4.78
Olfactory epithelial cells, donor3	11935-125I9	27.01	3.41
Olfactory epithelial cells, donor4	11936-126A1	32.82	2.43
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	5.42
Osteoblast - differentiated, donor1	11276-116H7	29.14	2.77
Osteoblast - differentiated, donor2	11353-117H3	27.43	4.57
Osteoblast - differentiated, donor3	11425-118G3	19.24	4.34
Osteoblast, donor1	11277-116H8	19.15	2.74
Osteoblast, donor2	11354-117H4	54.08	15.45
Osteoblast, donor3	11426-118G4	33.06	6.75
Pancreatic stromal cells, donor1	11249-116E7	42.12	4.89
Pericytes, donor1	11491-119E6	6.23	0.45
Pericytes, donor2	11571-120E5	6.56	1.36
Pericytes, donor3	11652-122E5	9.77	2.44
Perineurial Cells, donor1	11499-119F5	34.47	4.75
Perineurial Cells, donor2	11579-120F4	27.97	5.24
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	231.40	36.66
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	129.53	20.32
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	142.75	25.62
Placental Epithelial Cells, donor1	11278-116H9	36.11	3.11
Placental Epithelial Cells, donor2	11355-117H5	29.94	2.22
Placental Epithelial Cells, donor3	11427-118G5	17.47	3.73
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	23.42	2.85
Preadipocyte - breast, donor1	11467-119B9	46.52	8.44
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.32	6.40
Preadipocyte - breast, donor2	11328-117E5	34.00	7.20
Preadipocyte - omental, donor1	11468-119C1	49.87	7.89
Preadipocyte - omental, donor2	11329-117E6	67.22	11.78
Preadipocyte - omental, donor3	11403-118D8	41.83	7.45
Preadipocyte - perirenal, donor1	11469-119C2	19.69	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	20.88	3.38
Preadipocyte - subcutaneous, donor2	11356-117H6	49.40	8.85
Preadipocyte - subcutaneous, donor3	11428-118G6	32.52	5.79
Preadipocyte - visceral, donor1	11280-116I2	68.65	12.11
Preadipocyte - visceral, donor2	11357-117H7	50.62	5.52
Preadipocyte - visceral, donor3	11429-118G7	35.53	7.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	51.89	9.50
Prostate Epithelial Cells, donor2	11331-117E8	27.35	6.36
Prostate Epithelial Cells, donor3	11404-118D9	48.32	5.51
Prostate Stromal Cells, donor1	11254-116F3	39.64	6.04
Prostate Stromal Cells, donor2	11332-117E9	31.02	5.74
Prostate Stromal Cells, donor3	11405-118E1	25.23	3.23
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.77	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.95	4.78
Renal Epithelial Cells, donor1	11517-119H5	6.09	0.51
Renal Epithelial Cells, donor2	11597-120H4	9.96	0.71
Renal Epithelial Cells, donor3	11678-122H4	45.31	5.50
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.21	3.23
Renal Glomerular Endothelial Cells, donor3	11675-122H1	37.52	6.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	2.66
Renal Mesangial Cells, donor1	11518-119H6	9.24	0.88
Renal Mesangial Cells, donor2	11598-120H5	12.54	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	23.89	3.49
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.57	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.56	3.37
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.06	2.56
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	52.19	5.52
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	82.05	9.62
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	46.46	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	64.39	17.06
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	79.47	28.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	90.89	24.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	59.19	10.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	79.19	15.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	102.21	24.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	57.34	13.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	81.13	15.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.91	13.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	74.43	15.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	66.12	13.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	51.07	11.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	62.35	12.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	58.64	13.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	50.09	17.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	66.15	15.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	108.99	22.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	69.54	17.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	65.90	15.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	67.60	16.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	60.55	15.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	71.76	13.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	73.66	16.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	58.89	17.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	62.67	13.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	67.16	12.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	53.54	18.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	59.72	13.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	70.86	17.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	54.12	19.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	88.48	20.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	66.63	16.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	60.83	20.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	81.74	19.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	72.88	18.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	65.85	21.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.44	15.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	85.20	22.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	53.00	15.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	75.75	18.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	71.97	19.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	50.19	10.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	51.67	11.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	80.01	13.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	39.65	10.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	54.85	9.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.21	9.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.12	9.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.37	20.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	44.42	10.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	42.80	13.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	41.84	8.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	51.82	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	56.32	13.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.02	8.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	41.47	11.42
Schwann Cells, donor1	11498-119F4	9.03	2.82
Schwann Cells, donor2	11578-120F3	17.01	3.40
Schwann Cells, donor3	11659-122F3	28.26	3.72
Sebocyte, donor1	11220-116B5	42.73	15.34
Sebocyte, donor2	11301-117B5	37.22	9.19
Sebocyte, donor3	11378-118B1	26.59	3.71
Sertoli Cells, donor1	11255-116F4	43.07	3.31
Sertoli Cells, donor2	11333-117F1	50.84	5.65
Skeletal Muscle Cells, donor1	11281-116I3	48.92	6.51
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.00
Skeletal Muscle Cells, donor3	11430-118G8	15.05	1.67
Skeletal Muscle Cells, donor4	11451-119A2	34.56	4.87
Skeletal Muscle Cells, donor5	11455-119A6	30.77	3.86
Skeletal Muscle Cells, donor6	11459-119B1	37.55	6.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	44.23	4.54
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.53	4.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	41.27	3.97
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.90	8.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.20	3.62
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.48	1.93
Skin - palm, donor1	10286-104F7	177.28	37.61
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	19.17	3.46
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	10.63
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.99	4.80
Small Airway Epithelial Cells, donor1	11256-116F5	46.29	8.06
Small Airway Epithelial Cells, donor2	11334-117F2	41.49	6.47
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	42.50	5.92
Small Airway Epithelial Cells, donor3	11406-118E2	46.32	5.70
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	29.93	5.55
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.68	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.63	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.57	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.08	5.12
Smooth Muscle Cells - Aortic, donor3	11432-118H1	31.68	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	38.03	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	22.76	3.99
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.58	4.21
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	34.95	7.68
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.65	3.58
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	30.42	6.50
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.22	2.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.48	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	40.19	3.96
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.69	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.10	3.10
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.45	3.44
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.25	3.04
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.13	4.18
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.74	2.99
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.93	3.22
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	51.33	12.18
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.08	9.78
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.72	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	66.76	9.01
Smooth Muscle Cells - Prostate, donor1	11257-116F6	36.89	6.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	32.56	5.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.62	3.80
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	37.54	9.80
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.21	5.58
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	27.26	6.06
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	18.18	7.83
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.68	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	69.23	9.75
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.89	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	18.28	4.32
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.44	4.59
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.17	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.22	7.13
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.57	3.60
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.67	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.08	3.43
Smooth Muscle Cells - Uterine, donor1	11258-116F7	31.37	6.85
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.11	3.80
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.30	2.33
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.51	3.17
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	36.45	10.79
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	33.06	6.47
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.91	7.95
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	29.54	9.06
Smooth muscle cells - airway, control, donor1	11966-126D4	27.43	5.08
Smooth muscle cells - airway, control, donor2	11967-126D5	16.37	2.00
Smooth muscle cells - airway, control, donor3	11968-126D6	24.24	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	25.21	5.04
Synoviocyte, donor1	11291-117A4	44.61	9.76
Synoviocyte, donor2	11368-117I9	27.49	5.53
Synoviocyte, donor3	11440-118H9	25.25	4.47
Trabecular Meshwork Cells, donor1	11532-120A2	17.87	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	9.49	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	29.32	4.30
Tracheal Epithelial Cells, donor2	11369-118A1	7.73	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	88.09	9.47
Urethra, donor2	10319-105A4	89.92	7.19
Urothelial Cells, donor1	11520-119H8	8.24	0.80
Urothelial Cells, donor2	11600-120H7	10.41	2.00
Urothelial Cells, donor3	11681-122H7	6.19	1.15
Urothelial cells, donor0	11216-116B1	44.80	4.68
Whole blood (ribopure), donor090309, donation1	12179-129A1	825.72	77.41
Whole blood (ribopure), donor090309, donation2	12180-129A2	1139.40	88.64
Whole blood (ribopure), donor090309, donation3	12181-129A3	610.59	36.96
Whole blood (ribopure), donor090325, donation1	12176-128I7	619.46	47.52
Whole blood (ribopure), donor090325, donation2	12177-128I8	621.12	55.20
Whole blood (ribopure), donor090612, donation1	12182-129A4	596.63	61.43
Whole blood (ribopure), donor090612, donation2	12183-129A5	831.52	87.19
Whole blood (ribopure), donor090612, donation3	12184-129A6	637.20	41.99
Wilms' tumor cell line:G-401	10809-111A8	44.53	8.76
Wilms' tumor cell line:HFWT	10597-108E3	74.80	11.44
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	46.65	5.87
achilles tendon, donor2	10292-104G4	45.46	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	57.11	11.47
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	112.14	23.22
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	93.07	12.70
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	179.60	57.96
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	93.88	33.45
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	147.19	50.33
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	66.69	20.96
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	65.21	15.42
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	102.50	32.26
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	69.89	11.26
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	123.83	42.14
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	139.66	48.80
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	149.39	42.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	73.65	22.80
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	75.76	7.44
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	100.35	22.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.94	6.45
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	71.69	14.51
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	57.02	13.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	70.77	12.04
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	78.85	27.84
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	70.71	10.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	260.15	63.18
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	119.02	29.76
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	110.34	30.09
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	183.70	54.36
adenocarcinoma cell line:IM95m	10796-110I4	42.15	11.77
adipose tissue, adult, pool1	10010-101C1	62.82	5.58
adipose, donor1	10184-103D4	74.47	11.14
adipose, donor2	10185-103D5	16.22	0.81
adipose, donor3	10186-103D6	38.94	3.81
adipose, donor4	10187-103D7	41.60	6.93
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	47.66	5.84
adrenal gland, adult, pool1	10081-102A9	14.55	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	47.09	11.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.53	11.79
amniotic membrane cells, donor1	12235-129G3	51.01	6.26
amniotic membrane cells, donor2	12236-129G4	46.32	5.75
amniotic membrane cells, donor3	12237-129G5	64.22	7.37
amygdala - adult, donor10196	10167-103B5	83.01	13.04
amygdala, adult, donor10252	10151-102I7	106.25	8.72
amygdala, newborn, donor10223	10360-105E9	40.35	10.01
anaplastic carcinoma cell line:8305C	10428-106D5	92.31	6.49
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	40.59	10.15
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.78	6.01
aorta, adult, pool1	10052-101G7	52.17	3.73
appendix, adult	10189-103D9	86.94	9.70
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	55.03	7.57
artery, adult	10190-103E1	58.42	4.08
astrocytoma cell line:TM-31	10425-106D2	86.05	13.62
b cell line:RPMI1788	10427-106D4	41.19	5.65
basal cell carcinoma cell line:TE 354.T	10702-109G9	49.39	9.16
bile duct carcinoma cell line:HuCCT1	10432-106D9	48.52	7.94
bile duct carcinoma cell line:TFK-1	10496-107C1	49.38	6.36
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	6.71
bladder, adult, pool1	10011-101C2	87.24	4.56
blood, adult, pool1	10053-101G8	504.93	39.86
bone marrow stromal cell line:StromaNKtert	10686-109F2	83.92	15.41
bone marrow, adult	10192-103E3	90.43	9.45
brain, adult, donor1	10084-102B3	39.98	7.18
brain, adult, pool1	10012-101C3	87.86	8.24
brain, fetal, pool1	10085-102B4	40.07	5.34
breast carcinoma cell line:MCF7	10482-107A5	107.04	15.20
breast carcinoma cell line:MDA-MB-453	10419-106C5	100.11	10.73
breast, adult, donor1	10080-102A8	36.62	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	42.81	5.08
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	66.48	16.08
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	45.12	6.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	46.72	11.14
carcinoid cell line:NCI-H1770	10703-109H1	50.78	7.52
carcinoid cell line:NCI-H727	10735-110B6	62.24	8.75
carcinoid cell line:SK-PN-DW	10719-109I8	51.02	5.70
carcinosarcoma cell line:JHUCS-1	10642-109A3	61.49	6.92
caudate nucleus - adult, donor10196	10177-103C6	80.59	8.06
caudate nucleus, adult, donor10252	10164-103B2	117.30	7.53
caudate nucleus, adult, donor10258	10379-105H1	84.82	9.17
caudate nucleus, newborn, donor10223	10354-105E3	48.71	6.96
cerebellum - adult, donor10196	10173-103C2	104.88	11.65
cerebellum, adult, donor10252	10166-103B4	150.52	8.33
cerebellum, adult, pool1	10083-102B2	49.33	5.86
cerebellum, newborn, donor10223	10357-105E6	65.59	9.96
cerebral meninges, adult	10188-103D8	94.05	12.35
cerebrospinal fluid, donor2	10294-104G6	75.28	12.43
cervical cancer cell line:D98-AH2	10552-107I3	111.72	14.23
cervical cancer cell line:ME-180	10553-107I4	93.30	13.92
cervix, adult, pool1	10013-101C4	84.10	6.30
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	70.51	6.69
chondrosarcoma cell line:SW 1353	10700-109G7	66.62	13.06
choriocarcinoma cell line:BeWo	10423-106C9	69.97	9.82
choriocarcinoma cell line:SCH	10785-110H2	26.00	3.20
choriocarcinoma cell line:T3M-3	10618-108G6	63.09	8.54
chorionic membrane cells, donor1	12238-129G6	32.20	2.28
chorionic membrane cells, donor2	12239-129G7	44.25	7.66
chorionic membrane cells, donor3	12240-129G8	51.65	6.59
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	136.32	29.28
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	72.23	17.48
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.50	15.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	147.92	33.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	156.50	35.07
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	159.22	42.76
chronic myelogenous leukemia cell line:K562	10454-106G4	203.17	52.12
chronic myelogenous leukemia cell line:KU812	10409-106B4	72.19	13.81
clear cell carcinoma cell line:JHOC-5	10638-108I8	20.34	3.20
clear cell carcinoma cell line:TEN	10636-108I6	14.92	1.39
colon carcinoma cell line:CACO-2	10513-107D9	49.06	8.42
colon carcinoma cell line:COLO-320	10420-106C6	69.17	9.50
colon, adult, donor1	10082-102B1	33.32	3.57
colon, adult, pool1	10014-101C5	77.79	9.40
colon, fetal, donor1	10070-101I7	45.11	1.85
common myeloid progenitor CMP, donor1	12130-128D6	183.34	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	66.29	14.45
cord blood derived cell line:COBL-a 24h infection	10453-106G3	51.17	13.89
cord blood derived cell line:COBL-a untreated	10449-106F8	56.97	15.65
corpus callosum, adult, pool1	10042-101F6	109.46	8.29
cruciate ligament, donor2	10295-104G7	76.18	5.67
diaphragm, fetal, donor1	10069-101I6	40.93	2.41
diencephalon, adult	10193-103E4	80.16	11.28
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	61.54	13.09
ductal cell carcinoma cell line:KLM-1	10438-106E6	156.43	22.82
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	48.14	8.18
ductus deferens, adult	10196-103E7	73.75	8.47
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	63.27	8.09
dura mater, adult, donor1	10041-101F5	109.92	10.49
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	26.43	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	57.75	6.45
embryonic pancreas cell line:1B2C6	10604-108F1	138.12	17.88
embryonic pancreas cell line:1C3D3	10605-108F2	63.87	4.24
embryonic pancreas cell line:1C3IKEI	10606-108F3	130.91	12.04
embryonic pancreas cell line:2C6	10603-108E9	179.94	24.96
endometrial carcinoma cell line:OMC-2	10497-107C2	54.64	8.38
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	72.86	6.71
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.65	6.43
epidermoid carcinoma cell line:A431	10426-106D3	92.15	13.12
epidermoid carcinoma cell line:Ca Ski	10431-106D8	84.14	13.86
epididymis, adult	10197-103E8	64.26	7.12
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	67.06	5.14
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	25.56	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	102.09	17.82
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	98.22	20.27
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	100.60	19.61
esophagus, adult, pool1	10015-101C6	69.33	5.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	61.62	5.76
eye - muscle inferior rectus, donor1	10272-104E2	111.07	4.83
eye - muscle lateral, donor2	10298-104H1	105.21	14.73
eye - muscle medial, donor2	10299-104H2	101.20	5.95
eye - muscle superior, donor2	10297-104G9	68.79	2.29
eye - vitreous humor, donor1	10268-104D7	55.38	8.74
eye, fetal, donor1	10054-101G9	44.75	2.54
fibrosarcoma cell line:HT-1080	10758-110E2	38.98	7.31
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	49.62	4.99
frontal lobe, adult, pool1	10040-101F4	105.36	12.95
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	68.76	13.21
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	68.30	7.95
gall bladder, adult	10198-103E9	64.70	5.31
gamma delta positive T cells, donor1	11937-126A2	150.32	23.08
gamma delta positive T cells, donor2	11938-126A3	147.90	31.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	74.56	16.90
gastric adenocarcinoma cell line:MKN45	10612-108F9	76.98	7.74
gastric cancer cell line:AZ521	10549-107H9	60.66	10.00
gastric cancer cell line:GSS	10560-108A2	28.37	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	30.61	4.34
giant cell carcinoma cell line:LU65	10487-107B1	62.30	6.43
giant cell carcinoma cell line:Lu99B	10433-106E1	52.62	4.62
glassy cell carcinoma cell line:HOKUG	10688-109F4	100.76	18.71
glioblastoma cell line:A172, tech_rep1	10444-106F3	49.72	7.18
glioblastoma cell line:A172, tech_rep2	10444-106F3	56.60	5.90
glioblastoma cell line:T98G	10485-107A8	33.77	4.53
glioma cell line:GI-1	10413-106B8	34.85	4.10
globus pallidus - adult, donor10196	10175-103C4	82.37	5.10
globus pallidus, adult, donor10252	10161-103A8	159.88	9.28
globus pallidus, adult, donor10258	10367-105F7	84.89	2.74
globus pallidus, newborn, donor10223	10364-105F4	38.37	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	141.93	14.68
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23
granulosa cell tumor cell line:KGN	10624-108H3	25.28	8.00
hIPS +CCl2, biol_rep1	14383-156B9	52.80	7.35
hIPS +CCl2, biol_rep2	14384-156C1	29.26	7.32
hIPS +CCl2, biol_rep3	14385-156C2	22.54	5.80
hIPS, biol_rep1	14380-156B6	28.75	12.94
hIPS, biol_rep2	14381-156B7	22.63	4.80
hIPS, biol_rep3	14382-156B8	58.48	8.83
hairy cell leukemia cell line:Mo	10712-109I1	50.86	16.09
heart - mitral valve, adult	10205-103F7	65.17	7.77
heart - pulmonic valve, adult	10206-103F8	81.06	5.49
heart - tricuspid valve, adult	10207-103F9	83.26	10.82
heart, adult, diseased post-infarction, donor1	10050-101G5	21.83	3.26
heart, adult, diseased, donor1	10051-101G6	44.29	2.98
heart, adult, pool1	10016-101C7	72.67	4.60
heart, fetal, pool1	10046-101G1	75.47	7.70
hepatic mesenchymal tumor cell line:LI90	10778-110G4	39.80	4.32
hepatoblastoma cell line:HuH-6	10633-108I3	68.97	15.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	49.50	14.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	54.38	12.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	60.43	12.43
hepatoma cell line:Li-7	10484-107A7	42.71	5.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	51.26	10.05
hippocampus - adult, donor10196	10169-103B7	83.28	11.36
hippocampus, adult, donor10252	10153-102I9	118.79	12.04
hippocampus, adult, donor10258	10374-105G5	65.23	13.44
hippocampus, newborn, donor10223	10363-105F3	32.08	5.29
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	67.14	17.09
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.49	7.46
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.13	8.12
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	24.81	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.66	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.23	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	36.79	5.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	31.45	5.39
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.03	6.26
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	44.04	7.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	31.98	5.14
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.03	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	32.86	4.54
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	34.39	6.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.09	7.85
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	31.50	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.96	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	23.99	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.39	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.47	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.05	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.68	4.08
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	26.42	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.73	3.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	40.83	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	30.81	5.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	50.22	11.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	34.86	5.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.02	4.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.33	5.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.06	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	29.22	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.53	5.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	27.35	4.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	23.19	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	39.12	5.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	48.58	12.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	33.17	6.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	27.20	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	299.30	65.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	42.69	8.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	40.50	7.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	30.76	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.98	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	40.58	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.22	6.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	20.20	2.69
immature langerhans cells, donor1	11904-125F5	93.47	17.19
immature langerhans cells, donor2	11905-125F6	32.48	7.92
insula, adult, pool1	10039-101F3	116.21	13.91
keratoacanthoma cell line:HKA-1	10791-110H8	41.62	8.78
kidney, adult, pool1	10017-101C8	121.45	16.92
kidney, fetal, pool1	10045-101F9	47.46	4.88
large cell lung carcinoma cell line:IA-LM	10509-107D5	123.27	21.73
large cell lung carcinoma cell line:NCI-H460	10839-111E2	28.20	4.70
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	112.67	9.91
left atrium, adult, donor1	10079-102A7	26.15	1.63
left ventricle, adult, donor1	10078-102A6	35.40	2.02
leiomyoblastoma cell line:G-402	10721-110A1	48.43	10.40
leiomyoma cell line:10964C	10569-108B2	27.30	4.31
leiomyoma cell line:15242A	10570-108B3	27.72	3.26
leiomyoma cell line:15425	10571-108B4	33.51	5.58
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	11.50
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	71.78	20.07
liposarcoma cell line:KMLS-1	10782-110G8	33.90	6.09
liposarcoma cell line:SW 872	10726-110A6	68.23	11.09
liver, adult, pool1	10018-101C9	70.33	9.72
liver, fetal, pool1	10086-102B5	25.40	3.76
locus coeruleus - adult, donor10196	10182-103D2	94.64	7.15
locus coeruleus, adult, donor10252	10165-103B3	106.30	8.86
locus coeruleus, adult, donor10258	10375-105G6	36.11	2.82
locus coeruleus, newborn, donor10223	10362-105F2	68.56	11.36
lung adenocarcinoma cell line:A549	10499-107C4	26.43	4.84
lung adenocarcinoma cell line:PC-14	10408-106B3	117.89	11.72
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.30	5.80
lung, adult, pool1	10019-101D1	64.14	4.96
lung, fetal, donor1	10068-101I5	138.14	17.98
lung, right lower lobe, adult, donor1	10075-102A3	42.16	2.29
lymph node, adult, donor1	10077-102A5	38.34	7.57
lymphangiectasia cell line:DS-1	10727-110A7	28.27	6.58
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	83.92	17.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	208.13	53.52
mature adipocyte, donor1	12231-129F8	88.35	3.11
mature adipocyte, donor2	12232-129F9	75.75	6.64
mature adipocyte, donor3	12233-129G1	85.82	3.56
mature adipocyte, donor4	12234-129G2	97.13	5.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	123.89	21.44
medial frontal gyrus - adult, donor10196	10170-103B8	55.27	20.30
medial frontal gyrus, adult, donor10252	10150-102I6	125.61	10.30
medial frontal gyrus, adult, donor10258	10368-105F8	55.91	6.99
medial frontal gyrus, newborn, donor10223	10352-105E1	124.53	37.53
medial temporal gyrus - adult, donor10196	10183-103D3	89.94	12.32
medial temporal gyrus, adult, donor10252	10156-103A3	123.94	11.88
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	71.27	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	932.98	100.48
medial temporal gyrus, newborn, donor10223	10353-105E2	37.33	12.92
medulla oblongata - adult, donor10196	10174-103C3	72.04	7.14
medulla oblongata, adult, donor10252	10155-103A2	100.62	8.67
medulla oblongata, adult, pool1	10038-101F2	104.81	10.12
medulla oblongata, newborn, donor10223	10361-105F1	48.26	7.29
medulloblastoma cell line:D283 Med	10838-111E1	44.06	13.51
medulloblastoma cell line:ONS-76	10759-110E3	45.00	7.95
melanoma cell line:COLO 679	10514-107E1	30.47	4.31
melanoma cell line:G-361	10465-106H6	74.65	11.13
meningioma cell line:HKBMM	10691-109F7	28.94	4.70
merkel cell carcinoma cell line:MKL-1	10843-111E6	99.57	24.67
merkel cell carcinoma cell line:MS-1	10844-111E7	100.06	19.96
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.14	7.21
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.90	5.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.92	6.63
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	32.03	6.46
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.23	2.70
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	5.55
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.37	2.92
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.62	3.22
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.54	6.10
mesenchymal precursor cell - cardiac, donor4	11755-123G9	30.92	7.97
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.13	6.40
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	22.40	4.61
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.59	4.15
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.91	3.84
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.75	4.08
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.89	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	18.72	2.07
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	23.03	3.88
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	52.44	13.43
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.52	4.03
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	22.93	2.63
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.19	3.68
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.31	2.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	52.63	8.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	28.77	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.37	6.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.89	6.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	29.27	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.48	4.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	28.09	7.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.94	3.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.56	6.49
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.90	5.48
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.56	5.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.84	5.77
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	37.40	12.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.15	6.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.02	4.50
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.94	6.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.50	6.17
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	11.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	34.12	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	6.22
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.09	6.52
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.20	5.70
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	27.94	4.14
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	13.78
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.00	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	23.69	3.43
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	7.10
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	12.84
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	27.54	7.57
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.79	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	3.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.81	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.02	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.07	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	159.39	21.66
mesothelioma cell line:ACC-MESO-1	10493-107B7	86.46	8.27
mesothelioma cell line:ACC-MESO-4	10494-107B8	34.29	2.32
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	12.82
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	42.85	4.93
mesothelioma cell line:Mero-25	10850-111F4	23.38	2.72
mesothelioma cell line:Mero-41	10851-111F5	45.72	9.05
mesothelioma cell line:Mero-48a	10852-111F6	42.51	10.85
mesothelioma cell line:Mero-82	10853-111F7	47.57	10.78
mesothelioma cell line:Mero-83	10854-111F8	34.21	6.81
mesothelioma cell line:Mero-84	10855-111F9	29.57	4.04
mesothelioma cell line:Mero-95	10856-111G1	31.47	5.59
mesothelioma cell line:NCI-H2052	10847-111F1	52.34	10.44
mesothelioma cell line:NCI-H226	10846-111E9	27.15	5.25
mesothelioma cell line:NCI-H2452	10848-111F2	38.61	3.93
mesothelioma cell line:NCI-H28	10845-111E8	44.53	7.13
mesothelioma cell line:No36	10857-111G2	30.66	4.57
mesothelioma cell line:ONE58	10858-111G3	54.19	6.23
migratory langerhans cells, donor1	11901-125F2	109.97	16.89
migratory langerhans cells, donor2	11902-125F3	63.01	12.82
migratory langerhans cells, donor3	11903-125F4	77.36	14.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.09	6.20
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.10	6.36
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	44.23	11.52
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.06	11.04
myelodysplastic syndrome cell line:SKM-1	10772-110F7	140.07	26.61
myeloma cell line:PCM6	10474-106I6	62.46	9.69
myxofibrosarcoma cell line:MFH-ino	10600-108E6	90.30	18.26
myxofibrosarcoma cell line:NMFH-1	10684-109E9	32.36	6.08
nasal epithelial cells, donor1, tech_rep1	12226-129F3	45.24	3.68
nasal epithelial cells, donor1, tech_rep2	12226-129F3	49.13	3.97
nasal epithelial cells, donor2	12227-129F4	18.22	2.76
neuroblastoma cell line:CHP-134	10508-107D4	87.88	17.94
neuroblastoma cell line:NB-1	10539-107G8	91.48	23.01
neuroblastoma cell line:NBsusSR	10607-108F4	35.22	7.38
neuroblastoma cell line:NH-12	10555-107I6	82.93	15.65
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.50	4.51
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	44.35	3.80
neuroectodermal tumor cell line:TASK1	10774-110F9	28.78	4.23
neuroepithelioma cell line:SK-N-MC	10728-110A8	108.08	7.63
neurofibroma cell line:Hs 53.T	10729-110A9	32.47	6.92
neutrophil PMN, donor1	12133-128D9	74.37	0.00
neutrophil PMN, donor2	12137-128E4	119.53	13.28
neutrophil PMN, donor3	12141-128E8	47.35	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	109.93	14.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	9.61
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	31.42	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.37	6.04
nucleus accumbens, adult, pool1	10037-101F1	105.08	10.87
occipital cortex - adult, donor10196	10172-103C1	90.66	22.66
occipital cortex, adult, donor10252	10163-103B1	130.96	6.17
occipital cortex, newborn, donor10223	10355-105E4	59.69	12.74
occipital lobe, adult, donor1	10076-102A4	54.32	8.66
occipital lobe, fetal, donor1	10073-102A1	67.80	5.58
occipital pole, adult, pool1	10036-101E9	61.97	5.99
olfactory region, adult	10195-103E6	84.64	12.42
optic nerve, donor1	10277-104E7	90.05	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	50.58	7.52
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	94.93	11.54
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	88.39	11.18
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.65	7.39
osteoclastoma cell line:Hs 706.T	10704-109H2	27.63	6.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	135.48	27.10
osteosarcoma cell line:HS-Os-1	10558-107I9	31.38	8.48
ovary, adult, pool1	10020-101D2	70.23	3.41
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.95	7.15
pancreas, adult, donor1	10049-101G4	51.74	6.58
pancreatic carcinoma cell line:NOR-P1	10698-109G5	42.49	10.06
papillary adenocarcinoma cell line:8505C	10437-106E5	69.84	10.39
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.39	12.75
paracentral gyrus, adult, pool1	10035-101E8	92.16	11.44
parietal cortex, adult, donor10258	10373-105G4	63.86	5.14
parietal lobe - adult, donor10196	10171-103B9	79.00	16.93
parietal lobe, adult, donor10252	10157-103A4	116.01	10.55
parietal lobe, adult, pool1	10034-101E7	90.68	11.90
parietal lobe, fetal, donor1	10072-101I9	76.62	9.70
parietal lobe, newborn, donor10223	10356-105E5	65.43	12.34
parotid gland, adult	10199-103F1	74.00	4.93
penis, adult	10200-103F2	60.16	7.52
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	65.26	4.65
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	57.40	8.60
pineal gland - adult, donor10196	10179-103C8	76.11	9.03
pineal gland, adult, donor10252	10160-103A7	143.91	11.84
pineal gland, adult, donor10258	10377-105G8	79.01	5.64
pituitary gland - adult, donor10196	10180-103C9	55.65	6.07
pituitary gland, adult, donor10252	10162-103A9	151.66	15.11
pituitary gland, adult, donor10258	10378-105G9	59.59	8.51
placenta, adult, pool1	10021-101D3	60.85	8.92
plasma cell leukemia cell line:ARH-77	10840-111E3	57.87	10.86
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.97	2.18
pons, adult, pool1	10033-101E6	85.72	11.36
postcentral gyrus, adult, pool1	10032-101E5	70.09	9.59
promyelocytes/myelocytes PMC, donor1	12132-128D8	125.48	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	58.99	7.87
prostate cancer cell line:PC-3	10439-106E7	74.78	15.97
prostate, adult, pool1	10022-101D4	74.19	6.26
putamen, adult, donor10196	10176-103C5	128.65	8.03
putamen, adult, donor10252	10152-102I8	103.92	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	69.94	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	80.46	6.77
putamen, newborn, donor10223	10365-105F5	64.47	16.49
rectal cancer cell line:TT1TKB	10469-106I1	66.04	11.93
rectum, fetal, donor1	10067-101I4	30.60	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	28.62	3.18
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	34.38	7.04
retina, adult, pool1	10030-101E3	66.80	4.67
retinoblastoma cell line:Y79	10475-106I7	39.23	6.50
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.26	5.90
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	68.05	6.47
sacrococcigeal teratoma cell line:HTST	10695-109G2	58.35	12.13
salivary acinar cells, donor1	11771-123I7	29.94	6.80
salivary acinar cells, donor2	11772-123I8	29.33	8.12
salivary acinar cells, donor3	11773-123I9	97.98	27.14
salivary gland, adult, pool1	10093-102C3	68.63	5.15
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	54.89	9.36
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.02	8.11
seminal vesicle, adult	10201-103F3	69.84	8.47
serous adenocarcinoma cell line:JHOS-2	10639-108I9	64.13	8.50
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.67	5.54
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	46.16	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.43	4.43
signet ring carcinoma cell line:Kato III	10436-106E4	62.12	6.41
signet ring carcinoma cell line:NUGC-4	10483-107A6	71.22	14.45
skeletal muscle - soleus muscle, donor1	10282-104F3	127.68	9.93
skeletal muscle, adult, pool1	10023-101D5	107.46	7.20
skeletal muscle, fetal, donor1	10066-101I3	32.16	1.01
skin, adult, donor1	10074-102A2	40.71	13.57
skin, fetal, donor1	10065-101I2	38.50	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	131.74	20.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	65.56	13.55
small cell lung carcinoma cell line:DMS 144	10841-111E4	35.47	5.20
small cell lung carcinoma cell line:LK-2	10541-107H1	114.39	23.90
small cell lung carcinoma cell line:NCI-H82	10842-111E5	58.07	7.24
small cell lung carcinoma cell line:WA-hT	10562-108A4	78.45	15.25
small intestine, adult, pool1	10024-101D6	82.54	18.04
small intestine, fetal, donor1	10064-101I1	34.15	5.41
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	110.79	22.05
smooth muscle, adult, pool1	10048-101G3	72.37	3.88
somatostatinoma cell line:QGP-1	10781-110G7	73.17	10.72
spinal cord - adult, donor10196	10181-103D1	92.22	6.42
spinal cord, adult, donor10252	10159-103A6	138.78	9.86
spinal cord, adult, donor10258	10369-105F9	69.18	11.07
spinal cord, fetal, donor1	10056-101H2	43.91	5.49
spinal cord, newborn, donor10223	10359-105E8	80.36	12.86
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	45.85	9.56
spleen, adult, pool1	10025-101D7	74.23	9.03
spleen, fetal, pool1	10044-101F8	73.73	8.58
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	37.06	6.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	93.04	8.92
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	39.84	7.69
squamous cell carcinoma cell line:T3M-5	10616-108G4	101.25	16.81
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	64.27	7.20
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	28.38	3.81
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	57.11	8.46
stomach, fetal, donor1	10062-101H8	86.51	6.41
submaxillary gland, adult	10202-103F4	52.98	10.82
substantia nigra - adult, donor10196	10178-103C7	379.92	0.00
substantia nigra, adult, donor10252	10158-103A5	110.50	8.72
substantia nigra, adult, donor10258	10371-105G2	55.86	8.79
substantia nigra, newborn, donor10223	10358-105E7	50.17	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	59.61	10.32
temporal lobe, adult, pool1	10031-101E4	61.54	7.63
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	71.94	14.25
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	72.52	16.70
tenocyte, donor1	11763-123H8	47.13	5.59
tenocyte, donor2	11765-123I1	33.95	4.20
tenocyte, donor3	11768-123I4	44.48	7.78
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	63.40	9.52
teratocarcinoma cell line:NCR-G1	10798-110I6	37.15	6.63
teratocarcinoma cell line:PA-1	10807-111A6	33.01	4.80
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.94	9.01
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.52	12.48
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	69.04	16.36
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	74.59	5.86
testis, adult, pool1	10026-101D8	86.43	9.02
testis, adult, pool2	10096-102C6	133.07	20.75
thalamus - adult, donor10196	10168-103B6	72.86	11.04
thalamus, adult, donor10252	10154-103A1	127.68	8.28
thalamus, adult, donor10258, tech_rep1	10370-105G1	90.84	6.16
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.61	2.96
thalamus, newborn, donor10223	10366-105F6	33.37	12.08
throat, adult	10209-103G2	50.68	6.24
throat, fetal, donor1	10061-101H7	52.71	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	67.17	8.35
thymus, adult, pool1	10027-101D9	120.09	10.94
thymus, fetal, pool1	10043-101F7	112.94	10.81
thyroid carcinoma cell line:KHM-5M	10776-110G2	46.80	5.05
thyroid carcinoma cell line:TCO-1	10783-110G9	78.37	11.59
thyroid, adult, pool1	10028-101E1	109.27	7.37
thyroid, fetal, donor1	10060-101H6	45.09	4.22
tongue epidermis (fungiform papillae), donor1	10288-104F9	113.95	6.16
tongue, adult	10203-103F5	55.82	8.14
tongue, fetal, donor1	10059-101H5	53.60	3.15
tonsil, adult, pool1	10047-101G2	86.85	10.92
trachea, adult, pool1	10029-101E2	62.41	6.87
trachea, fetal, donor1	10058-101H4	46.55	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.59	7.09
transitional-cell carcinoma cell line:5637	10418-106C4	63.22	12.87
transitional-cell carcinoma cell line:JMSU1	10492-107B6	59.07	8.15
tridermal teratoma cell line:HGRT	10694-109G1	131.27	17.12
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	37.75	6.35
umbilical cord, fetal, donor1	10057-101H3	33.38	4.17
uterus, adult, pool1	10100-102D1	79.17	7.00
uterus, fetal, donor1	10055-101H1	45.56	4.10
vagina, adult	10204-103F6	78.19	4.52
vein, adult	10191-103E2	70.14	6.14
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.76	2.94